Clinical Routine

AI-based
Clinical Decision
Support Systems

Clinical Routine

AI-based
Clinical Decision
Support Systems

From Image to InSight with RetInSight: Identify disease activity & therapeutic response in GA and nAMD

RetInSight is your partner in advancing ophthalmology with AI.

We bring transformative AI-based medical software to eye care professionals, revolutionizing the management of all types of age-related macular degeneration (AMD), e.g. intermediate AMD, geographic atrophy (GA), and neovascular (n)AMD.

Leading in AI innovations:
Data-driven insights for time-saving precision care

Pioneering MDR CE-certified AI for eye care professionals

RetInSight is the first company to introduce MDR CE-certified AI solutions for use in clinical routine by eye care professionals. We offer AI-based OCT image analyses with a clear mission: Empowering eye care professionals to offer optimal management of retinal disease to every patient.

Seamless integration into current OCT routine

The solutions are intended to be compatible with routine OCT systems and are integrated in the following PAC systems (PACS = Picture Archiving and Communication System):

  • Heidelberg Engineering Spectralis OCT with HEYEX 2.6 / AppWay, and
  • Topcon Triton OCT with Harmony,
  • as well as by a customized autonomous tool. 

Compliance-driven 

Regulatory requirements, including FDA regulations in the U.S. and MDR in Europe, mandate that AI algorithms be validated and certified individually for each device, ensuring full regulatory compliance for every specific OCT system.

Regulatory excellence

Our medical software fulfills highest quality and regulatory compliance standards: GDPR, HIPAA, MDR 2017/745, ISO 13485, ISO 27001.

Explore our advanced AI solutions for clinical routine

RetInSight GA Monitor

Revolutionize the management of Geographic Atrophy (GA) with our AI-driven GA Monitor. Accurate disease assessment and treatment evaluation at your fingertips.

learn more

RetInSight Fluid Monitor

Stay ahead in the battle against neovascular Age-Related Macular Degeneration (nAMD). Our Fluid Monitor leverages AI for precise fluid quantification and treatment response analysis.

learn more

Our AI-based clinical decision support systems offer:

  • Precise and objective assessment of disease activity and therapeutic benefit by routine OCT
  • Customized PDF report for physicians and patients in real-time
  • Fully automated visualization and quantification to support an efficient workflow

Experience precision and insight firsthand: Your journey from image to insight starts with RetInSight.

Request a demo of our transformative Fluid Monitor and GA Monitor to experience the future of efficient ophthalmology care today. 

Request a Demo